RBC Capital keeps four stocks at Outperform and raises price targets
RBC Capital kept Outperform ratings on Jazz Pharmaceuticals, Ensign Group, Realty Income and Neurocrine Biosciences and raised the price target on each.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
RBC Capital on November 3 kept Outperform ratings on four companies at once and raised the price target on each, according to TradingView, which cites Benzinga data. The Jazz Pharmaceuticals target rose to $305 from $296, a 3.0% increase, compared with a November 2 close of $214.44.
The Ensign Group target went to $239 from $228, up 4.8%, against a close of $179.06. Realty Income's target is now $61, versus $60 before, a 1.7% rise, with shares closing at $57.58. Neurocrine Biosciences' target moved up to $190 from $187, or 1.6%, against a close of $145.35.
why it matters
Changes like these are routine analyst updates. The implied upside figures reflect the bank's own valuation gap, not a forecast of share price moves. Views on these stocks differ: Barclays, for example, keeps Jazz at Overweight with a $275 target, below RBC's new level.
tags
instruments
sources
- RBC Capital maintains Jazz Pharmaceuticals at Outperform, raises price target to $305 from $296 — TradingView, 3 November 2026 at 15:00 UTC
- RBC Capital maintains Ensign Group at Outperform, raises price target to $239 from $228 — TradingView, 3 November 2026 at 15:07 UTC
- RBC Capital maintains Realty Income at Outperform, raises price target to $61 from $60 — TradingView, 3 November 2026 at 15:06 UTC
- RBC Capital maintains Neurocrine Biosciences at Outperform, raises price target to $190 from $187 — TradingView, 3 November 2026 at 15:04 UTC
- RBC Capital maintains Vertex Pharmaceuticals at Outperform, raises price target to $600 from $576 — TradingView, 3 November 2026 at 15:12 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗